A PON for all seasons: comparing paraoxonase enzyme substrates, activity and action including the role of PON3 in health and disease

CJ Mohammed, S Lamichhane, JA Connolly… - Antioxidants, 2022 - mdpi.com
Paraoxonases (PONs) are a family of hydrolytic enzymes consisting of three members,
PON1, PON2, and PON3, located on human chromosome 7. Identifying the physiological …

The impact of dyslipidemia and oxidative stress on vasoactive mediators in patients with renal dysfunction

M Jabarpour, N Rashtchizadeh, H Argani… - … Urology and Nephrology, 2019 - Springer
Hyperlipidemia and oxidative stress are indispensable features of chronic kidney disease
(CKD) that favor the development of atherogenic plaques and cardiovascular disease …

Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity

G Aggarwal, LS May-Zhang, V Yermalitsky… - Journal of Biological …, 2021 - ASBMB
Reduced activity of paraoxonase 1 (PON1), a high-density lipoprotein (HDL)-associated
enzyme, has been implicated in the development of atherosclerosis. Post-translational …

HDL in COVID-19 patients: Evidence from an Italian cross-sectional study

B Papotti, C Macchi, C Favero, S Iodice… - Journal of clinical …, 2021 - mdpi.com
A number of studies have highlighted important alterations of the lipid profile in COVID-19
patients. Besides the well-known atheroprotective function, HDL displays anti-inflammatory …

Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease

MV Milaciu, ȘC Vesa, IC Bocșan… - Journal of clinical …, 2019 - mdpi.com
Background: Non-alcoholic fatty liver disease (NAFLD) is an important cause of chronic liver
diseases around the world. Paraoxonase-1 (PON1) is an enzyme produced by the liver with …

Cardioprotective role for paraoxonase-1 in chronic kidney disease

P Dube, FK Khalaf, A DeRiso, CJ Mohammed… - Biomedicines, 2022 - mdpi.com
Paraoxonase-1 (PON-1) is a hydrolytic enzyme associated with HDL, contributing to its anti-
inflammatory, antioxidant, and anti-atherogenic properties. Deficiencies in PON-1 activity …

Understanding the heterogeneity and dysfunction of HDL in chronic kidney disease: insights from recent reviews

Z Xu, S Yang, L Cui - BMC nephrology, 2024 - Springer
Chronic kidney disease (CKD) is a complex disease that affects the global population's
health, with dyslipidemia being one of its major complications. High density lipoprotein …

Paraoxonases at the Heart of Neurological Disorders

FK Khalaf, J Connolly, B Khatib-Shahidi… - International Journal of …, 2023 - mdpi.com
Paraoxonase enzymes serve as an important physiological redox system that participates in
the protection against cellular injury caused by oxidative stress. The PON enzymes family …

Paraoxonase-1 regulation of renal inflammation and fibrosis in chronic kidney disease

FK Khalaf, CJ Mohammed, P Dube, JA Connolly, A Lad… - Antioxidants, 2022 - mdpi.com
Papraoxonase-1 (PON1) is a hydrolytic lactonase enzyme that is synthesized in the liver and
circulates attached to high-density lipoproteins (HDL). Clinical studies have demonstrated …

Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionality

A Mahrooz, Y Shokri, A Variji, M Zargari… - Nutrition, Metabolism …, 2021 - Elsevier
Background and aims Develo** laboratory assays to evaluate HDL functions and improve
cardiovascular disease (CVD) risk assessment has recently emerged as a challenge. The …